SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Level 8, 210 George Street, Sydney NSW 2000 GPO Box 3993 Sydney NSW 2001
Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)The suspension of trading in the securities of Imagion Biosystems Limited will be lifted immediately following lodgement of its Annual Report for the period ending 31 December 2023 and a release of an announcement relating to the appointment of a director. | 14/06/2024 |
The company releases the results of its meeting. | 31/05/2024 |
The company releases its AGM Investor Presentation. | 31/05/2024 |
The company releases its Chairman's Address to Shareholders. | 31/05/2024 |
The company releases its prospectus with a placement of 242,000 Convertible Notes with a face value of $1.00 per Convertible Note and a subscription price of $0.90909 to raise a maximum of approximately $220,000 before costs and grant of 2,048,122 Options. | 21/05/2024 |
The company will be re-instated to official quotation once a new Australian Director is appointed, following the release of its 2023 Annual Report. The ASX will re-instate IBX once it meets s201A(2) of the Corporationorafions Act. | 14/05/2024 |
The company releases its notification of cessation of securities. | 10/05/2024 |
The company releases its Appendix 4G and Corporate Governance Statement. | 10/05/2024 |
The company releases its 2023 Annual Report to shareholders. | 10/05/2024 |
The annual general meeting will be held at Level 25, 525 Collins Street, Melbourne VIC 3000 and virtually via the online platform https://www.web.lumiagm.com/367489986 on Friday 31 May 2024 at 10.00am (AEST). | 03/05/2024 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 30/04/2024 |
The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Tuesday, 2 April 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 28 March 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 02/04/2024 |
The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Tuesday, 2 April 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 28 March 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 02/04/2024 |
The suspension of trading in the securities of Imagion Biosystems Limited will be lifted immediately, following the release by IBX of an announcement regarding a proposed capital raising. | 20/09/2018 |
The company announces a pro-rata non-renounceable rights issue to shareholders on the basis of 1 new share for every 2 imagion shares held as at 7.00pm (Melbourne time) Friday 28 September 2018. The funds will finance the company's first in-human study for metastatic breast cancer and for general working capital. The rights issue will be for an issue price of $0.04 per share to raise up to $4.3 million. There will be a shortfall facility to enable applications for additional shares. | 20/09/2018 |
The securities of Imagion Biosystems Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of IBX, pending the release of an announcement regarding a capital raising. | 17/09/2018 |
listed entity carried for record purposes only | 22/06/2017 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 16/09/2025 | Nina Webster | 565,211 | $0.036 | $20,303.00 |
| 27/06/2024 | Brett Mitchell | 20,908 | $0.083 | $1,744.00 |
| 19/06/2024 | Brett Mitchell | 500,000 | $0.081 | $40,499.00 |
| 12/09/2022 | Dianne Angus | 243,000 | $0.037 | $8,991.00 |
| 24/11/2017 | Robert Proulx | 235,000 | $0.100 | $23,383.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Robert Proulx | Executive Chairman | 08/12/2016 |
| Brett Mitchell | Non Exec Director | 14/06/2024 |
| Nina Webster | Non Exec Director | 01/09/2025 |
| Melanie Leydin | Non Exec Director, Company Secretary | 13/05/2024 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
